| Ask Questions (ASQ):Implementation of a Communication Intervention (NCT05025748) | Barbara Ann Karmanos Cancer Institute | 2021-08-25 |
| Researching the Effect of Exercise on Cancer (NCT04589468) | City of Hope Medical Center | 2020-10-02 |
| Acupuncture Pilot Study for Cancer-related Cognitive Function (NCT04007770) | Memorial Sloan Kettering Cancer Center | 2019-07-01 |
| Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer (NCT03880422) | Roswell Park Cancer Institute | 2019-05-02 |
| Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer (NCT03477864) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2018-12-24 |
| Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners (NCT03112668) | Rutgers, The State University of New Jersey | 2017-12-06 |
| Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer (NCT03103321) | Alliance for Clinical Trials in Oncology | 2017-10-02 |
| Visually Enhanced Education About Prostate Cancer (NCT02846870) | Vanderbilt-Ingram Cancer Center | 2016-09-01 |
| sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer (NCT02767921) | University of Southern California | 2016-08-02 |
| Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations (NCT02646319) | Mayo Clinic | 2016-01-01 |
| Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer (NCT02278185) | University of Colorado, Denver | 2015-11-11 |
| Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate Cancer (NCT02605226) | Tianjin Medical University Cancer Institute and Hospital | 2015-11-01 |
| Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy (NCT02420652) | Rutgers, The State University of New Jersey | 2015-06-23 |
| Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery (NCT02144649) | Ohio State University Comprehensive Cancer Center | 2015-06-01 |
| Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer (NCT02048150) | City of Hope Medical Center | 2015-03-13 |
| Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer (NCT02217709) | University of Southern California | 2014-09-08 |
| Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer (NCT02296229) | Jonsson Comprehensive Cancer Center | 2014-01-27 |
| Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery (NCT01912820) | Jonsson Comprehensive Cancer Center | 2014-01-01 |
| Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery (NCT01923506) | City of Hope Medical Center | 2013-11-25 |
| Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery (NCT02603965) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2013-08-01 |
| Cabozantinib in Men With Castration-Resistant Prostate Cancer (NCT01703065) | University of Washington | 2013-06-18 |
| Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer (NCT01731912) | University of Washington | 2013-05-01 |
| Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing Surgery (NCT01823562) | Ohio State University Comprehensive Cancer Center | 2012-10-17 |
| High-Dose Stereotactic Radiation for Prostate Cancer (NCT01664130) | Case Comprehensive Cancer Center | 2012-07-01 |
| Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel (NCT01469338) | University of Southern California | 2012-07-01 |
| Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy (NCT01555632) | University of Nebraska | 2012-03-01 |
| Axitinib Before Surgery in Treating Patients With High-Risk Prostate Cancer (NCT01385059) | City of Hope Medical Center | 2011-10-28 |
| Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer (NCT00996749) | Wake Forest University Health Sciences | 2011-05-01 |
| Genistein in Treating Patients With Prostate Cancer (NCT01126879) | Northwestern University | 2011-02-03 |
| Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients (NCT01882985) | University of California, Irvine | 2010-12-01 |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT01155258) | University of Southern California | 2010-06-01 |
| Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer (NCT01117935) | Virginia Commonwealth University | 2010-05-30 |
| Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer (NCT01023061) | University of Washington | 2010-03-01 |
| Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer (NCT00956163) | National Cancer Institute (NCI) | 2010-03-01 |
| Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients (NCT00879619) | John P. Fruehauf | 2009-07-01 |
| Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy (NCT00937768) | Mayo Clinic | 2009-07-01 |
| MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate (NCT01028885) | Abramson Cancer Center at Penn Medicine | 2009-06-01 |
| Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer (NCT00450749) | National Cancer Institute (NCI) | 2008-02-01 |
| Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer (NCT00589472) | National Cancer Institute (NCI) | 2007-11-01 |
| Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy (NCT01656304) | Barbara Ann Karmanos Cancer Institute | 2007-05-01 |
| Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer (NCT00466752) | University of Washington | 2006-12-01 |
| Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer (NCT00536991) | Roswell Park Cancer Institute | 2006-10-01 |
| A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer (NCT00108732) | National Cancer Institute (NCI) | 2006-02-01 |
| Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate Cancer (NCT00103194) | National Cancer Institute (NCI) | 2005-09-01 |
| Cilengitide in Treating Patients With Prostate Cancer (NCT00121238) | National Cancer Institute (NCI) | 2005-01-01 |
| Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer (NCT00170157) | Mayo Clinic | 2004-06-01 |
| Perifosine in Treating Patients With Recurrent Prostate Cancer (NCT00058214) | National Cancer Institute (NCI) | 2003-03-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |
| Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer (NCT00003517) | Burzynski Research Institute | |